India, Aug. 8 -- EQL Pharma AB (EQL.ST) released earnings for second quarter that Drops, from last year
The company's bottom line came in at SEK9.82 million, or SEK0.33 per share. This compares with SEK10.41 million, or SEK0.36 per share, last year.
The company's revenue for the period rose 29.5% to SEK107.21 million from SEK82.78 million last year.
EQL Pharma AB earnings at a glance (GAAP) :
-Earnings: SEK9.82 Mln. vs. SEK10.41 Mln. last year.-EPS: SEK0.33 vs. SEK0.36 last year.-Revenue: SEK107.21 Mln vs. SEK82.78 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....